biomanufacturing
Canada Backs Aspect Biosystems With $280M to Scale Bioprinted Tissue Therapies
The Government of Canada is supporting bioprinting company Aspect Biosystems with a new $280 million project to help develop and manufacture its bioengineered cellular medicines. The project will run over…
Canadian Government Invests $75M More in Aspect Biosystems
Canadian bioprinting startup Aspect Biosystems has received a $72.75 million investment from Canada and the province of British Columbia. This supports earlier investments amounting to $200 million in Aspect’s technology…
